About us
Platform
Pipeline
Overview
Azelaprag (BGE-105)
BGE-100
Media
Press releases
In the news
Events
Multimedia
Publications
Podcast
Careers
Explore
Press releases
BioAge Appoints Renowned Cardiologist and Biopharma Entrepreneur Michael H. Davidson, MD, to its Board of Directors
April 9, 2024
BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics
February 13, 2024
BioAge Labs Announces Plans for Phase 2 Trial of First-in-Class Apelin Receptor Agonist BGE-105/Azelaprag Co-Administered With Tirzepatide for Treatment of Obesity, in Collaboration With Lilly’s Chorus Organization
October 26, 2023
BioAge Labs Appoints BJ Sullivan as Chief Strategy Officer
May 22, 2023
Show more
Home
About us
Platform
Pipeline
Overview
Azelaprag (BGE-105)
BGE-100
Media
Press releases
In the news
Events
Multimedia
Publications
Podcast
Careers
